752 Pill - white & yellow capsule/oblong, 11mm
Pill with imprint 752 is White & Yellow, Capsule/Oblong and has been identified as Temozolomide 20 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 752
Temozolomide
- Imprint
- 752
- Strength
- 20 mg
- Color
- White & Yellow
- Size
- 11.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0752
- Inactive Ingredients
-
alcohol,
ammonia,
lactose anhydrous,
butyl alcohol,
ferric oxide yellow,
ferrosoferric oxide,
gelatin,
isopropyl alcohol,
potassium hydroxide,
propylene glycol,
shellac,
silicon dioxide,
sodium lauryl sulfate,
sodium starch glycolate type B potato,
stearic acid,
tartaric acid,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "752"
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.